• Study on ABBV-400 with Fluorouracil, Folinic Acid, and Bevacizumab for Adults with Unresectable Metastatic Colorectal Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Germany Spain

  • Study on Early Treatment with Teclistamab and Talquetamab for Patients with Newly Diagnosed High-Risk Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Methoxsalen for Treating Immune-Related Side Effects in Patients After Immunotherapy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study of Abemaciclib and Giredestrant for Patients with Early Stage ER-Positive, HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury

    Not recruiting

    3 1 1
    Investigated drugs:
    Belgium Czechia France Germany Hungary Italy +3

  • Study on the Safety of Lutetium (177Lu) Oxodotreotide with Arginine and Lysine in Children with Refractory or Recurrent Neuroblastoma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Denmark Finland Germany Italy +3

  • Study on Personalized Linezolid Dosing for Patients with Sepsis

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Title: Study of gene therapy Etranacogene Dezaparvovec (Hemgenix) in adult patients with moderate to severe Hemophilia B

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark Germany Ireland The Netherlands Sweden

  • Study of Ibrutinib for Patients with Chronic Lymphocytic Leukemia and TP53 Mutations

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

powered by